Clincosm LogoSign in Get a demo

ovarian cancer

Showing NaN - NaN of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors Trial in Worldwide (biological, drug, other)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Pembrolizumab
  • +4 more
  • Phoenix, Arizona
  • +178 more
Jan 25, 2023

Ovarian Cancer Trial in Worldwide (Ipatasertib, Cobimetinib, Trastuzumab Emtansine)

Recruiting
  • Ovarian Cancer
  • Tucson, Arizona
  • +60 more
Jan 20, 2023

Advanced Cancer, Metastatic Cancer, Ovarian Cancer Trial in Sarasota, Nashville (DS-9606a)

Recruiting
  • Advanced Cancer
  • +3 more
  • Denver, Colorado
  • +6 more
Jan 12, 2023

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting
  • Advanced Malignancies
  • +4 more
  • Fayetteville, Arkansas
  • +61 more
Jan 10, 2023

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
Has Results
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • Ovarian Cancer
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Scottsdale, Arizona
  • +46 more
Dec 29, 2022

Biliary Tract Cancer (BTC), Colorectal Cancer (CRC), Endometrial Cancer Trial in Belgium, United Kingdom, United States

Completed
  • Biliary Tract Cancer (BTC)
  • +5 more
  • Birmingham, Alabama
  • +9 more
Dec 22, 2022

Ovarian Cancer Trial in Worldwide (AZD2281, matching )

Active, not recruiting
Has Results
  • Ovarian Cancer
  • Berkeley, California
  • +73 more
Dec 19, 2022

Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in United Kingdom (AVA6000)

Recruiting
  • Pancreatic Cancer
  • +7 more
  • Glasgow, United Kingdom
  • +5 more
Nov 24, 2022

Ovarian Cancer Trial in Worldwide (Alpelisib, Olaparib, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +116 more
Nov 25, 2022

Ovarian Cancer Trial in Worldwide (Olaparib, Cediranib)

Recruiting
  • Ovarian Cancer
  • Sydney, New South Wales, Australia
  • +53 more
Sep 26, 2022

Investigate Adaptation and Evolution of Ovarian High-grade

Recruiting
  • Ovarian Cancer
  • +6 more
    • Bristol, United Kingdom
    • +10 more
    Sep 8, 2022

    Ovarian Epithelial Cancer, Carcinoma in Situ, Ovarian Cancer Trial in Worldwide (Lavage of the Cavum uteri and proximal

    Completed
    • Ovarian Epithelial Cancer
    • +2 more
    • Lavage of the Cavum uteri and proximal Fallopian tubes, performed in the luteal phase of the female cycle
    • Graz, Austria
    • +13 more
    Sep 1, 2022

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022

    Ovarian Cancer, Breast Cancer Trial in Worldwide (Olaparib)

    Enrolling by invitation
    • Ovarian Cancer
    • Breast Cancer
    • Boca Raton, Florida
    • +98 more
    Aug 22, 2022

    Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

    Active, not recruiting
    • Advanced Solid Tumors
    • +7 more
    • Duarte, California
    • +87 more
    Aug 19, 2022

    Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer Trial in Worldwide (BT5528,

    Recruiting
    • Advanced Solid Tumor Historically Known for High EphA2 Expression
    • +6 more
    • Encinitas, California
    • +27 more
    Aug 17, 2022

    Melanoma, Breast Cancer, Uterine Cancer Trial in London (MRx0518 Capsules, MRx0518/ Capsules)

    Active, not recruiting
    • Melanoma
    • +9 more
    • MRx0518 Capsules
    • MRx0518/placebo Capsules
    • London, United Kingdom
      Imperial College Healthcare NHS Trust
    Aug 10, 2022

    Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

    Not yet recruiting
    • Endometrial Cancer
    • +4 more
    • Datopotamab deruxtecan (Dato-DXd)
    • +8 more
    • Los Angeles, California
    • +52 more
    Aug 3, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • +12 more
    • San Francisco, California
    • +44 more
    Jul 12, 2022

    Advanced Cancer, Metastatic Cancer, Ovarian Cancer Trial in United Kingdom, United States (ART0380, Gemcitabine, Irinotecan)

    Recruiting
    • Advanced Cancer
    • +4 more
    • Denver, Colorado
    • +10 more
    Jul 6, 2022

    Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

    Recruiting
    • Ovarian Cancer
    • +10 more
    • West Hollywood, California
    • +27 more
    Jun 27, 2022

    Prostate Cancer, Non Small Cell Lung Cancer, Ovarian Cancer Trial in London, Oxford (OVM-200)

    Recruiting
    • Prostate Cancer
    • +2 more
    • OVM-200
    • London, United Kingdom
    • +2 more
    Apr 26, 2022

    Ovarian Cancer Trial in Hungary, United Kingdom, United States (EP0057, Olaparib tablets)

    Recruiting
    • Ovarian Cancer
    • Lady Lake, Florida
    • +15 more
    Mar 29, 2022